引用本文:陈 博,张 露,王青龙(综述),周 强(审校).宫颈癌FIGO分期ⅢC期诊治的研究进展[J].中国临床新医学,2022,15(3):278-282.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1498次   下载 1053 本文二维码信息
码上扫一扫!
分享到: 微信 更多
宫颈癌FIGO分期ⅢC期诊治的研究进展
陈 博,张 露,王青龙(综述),周 强(审校)
637000 四川,川北医学院(陈 博,王青龙);629000 四川,遂宁市中心医院肿瘤中心(陈 博,张 露,王青龙,周 强)
摘要:
[摘要] 肿瘤的分期对指导治疗及判断预后具有重要意义。2018年国际妇产科联盟(FIGO)发布了新的宫颈癌分期标准,首次将盆腔及腹主动脉旁淋巴结转移纳入分期,并单独归为ⅢC期。该文就宫颈癌ⅢC期相关问题以及国内外临床实践相关研究进行综述。
关键词:  宫颈癌  分期  诊治  预后
DOI:10.3969/j.issn.1674-3806.2022.03.20
分类号:R 737.33
基金项目:
Research progress in diagnosis and treatment of cervical cancer with FIGO stage ⅢC
CHEN Bo, ZHANG Lu, WANG Qing-long, et al.
North Sichuan Medical College, Sichuan 637000, China
Abstract:
[Abstract] The staging of tumors is of great significance in guiding treatment and predicting prognosis. In 2018, the International Federation of Gynecology and Obstetrics(FIGO) released new staging criteria for cervical cancer, which included pelvic and para-aortic lymph node metastasis in the staging of cervical cancer for the first time and classified it as stage ⅢC separately. In this paper, we review the related issues of cervical cancer with FIGO stage ⅢC and the related studies on clinical practice at home and abroad.
Key words:  Cervical cancer  Staging  Diagnosis and treatment  Prognosis